Patents Assigned to AVIDITY BIOSCIENCES LLC
  • Compositions and methods of treating muscle atrophy and myotonic dystrophy
    Patent number: 11583591
    Abstract: Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating muscle atrophy or myotonic dystrophy.
    Type: Grant
    Filed: September 1, 2021
    Date of Patent: February 21, 2023
    Assignee: AVIDITY BIOSCIENCES LLC
    Inventors: Andrew John Geall, Venkata Ramana Doppalapudi, David Sai-Ho Chu, Michael Caramian Cochran, Michael Hood, Beatrice Diana Darimont, Rob Burke, Yunyu Shi, Gulin Erdogan Marelius, Barbora Malecova
  • Nucleic acid-polypeptide compositions and methods of inducing exon skipping
    Patent number: 11311627
    Abstract: Disclosed herein are molecules and pharmaceutical compositions that induce an insertion, deletion, duplication, or alteration in an incorrectly spliced mRNA transcript to induce exon skipping or exon inclusion. Also described herein include methods for treating a disease or disorder that comprises a molecule or a pharmaceutical composition that induces an insertion, deletion, duplication, or alteration in an incorrectly spliced mRNA transcript to induce exon skipping or exon inclusion.
    Type: Grant
    Filed: August 31, 2021
    Date of Patent: April 26, 2022
    Assignee: AVIDITY BIOSCIENCES LLC
    Inventors: Arthur A. Levin, Andrew John Geall, Venkata Ramana Doppalapudi, Michael Caramian Cochran, Hanhua Huang, Rob Burke